LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study.

    Kamrul-Hasan, A B M / Alam, Muhammad Shah / Kabir, Md Ahamedul / Chowdhury, Sumon Rahman / Hannan, Muhammad Abdul / Chowdhury, Emran Ur Rashid / Ahsan, Md Mainul / Mohana, Choman Abdullah / Iftekhar, Mohammad Hasan / Hasan, Mohammad Jahid / Talukder, Samir Kumar

    Journal of clinical & translational endocrinology

    2023  Volume 31, Page(s) 100315

    Abstract: Aims: To risk-stratify patients with type 2 diabetes mellitus (T2DM) according to the IDF-DAR 2021 guidelines and observe their responsiveness to risk-category-based recommendations and fasting experience.: Methods: This prospective study, conducted ... ...

    Abstract Aims: To risk-stratify patients with type 2 diabetes mellitus (T2DM) according to the IDF-DAR 2021 guidelines and observe their responsiveness to risk-category-based recommendations and fasting experience.
    Methods: This prospective study, conducted in the
    Results: Among 1328 participants (age 51.1 ± 11.9 years, female 61.1 %), only 29.6 % had pre-Ramadan HbA1c < 7.5 %. According to the IDF-DAR risk category, the frequencies of participants in the low-risk (should be able to fast), moderate-risk (not to fast), and high-risk (should not fast) groups were 44.2 %, 45.7 %, and 10.1 %, respectively. Most (95.5 %) intended to fast, and 71 % fasted the full 30 days of Ramadan. The overall frequencies of hypoglycemia (3.5 %) and hyperglycemia (2.0 %) were low. Hypoglycemia and hyperglycemia risks were 3.74-fold and 3.86-fold higher in the high-risk group than in the low-risk group.
    Conclusion: The new IDF-DAR risk scoring system seems conservative in the risk categorization of T2DM patients in terms of fasting complications.
    Language English
    Publishing date 2023-02-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2834222-7
    ISSN 2214-6237 ; 2214-6237
    ISSN (online) 2214-6237
    ISSN 2214-6237
    DOI 10.1016/j.jcte.2023.100315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Genetic Diversity Analysis and Molecular Screening for Salinity Tolerance in Wheat Germplasm

    Hannan, Muhammad Abdul / Saha, Nihar Ranjan / Roy, Swapan Kumar / Woo, Sun-Hee / Shahidul, Muhammad

    Plant breeding and biotechnology

    2021  Volume 9, Issue 3, Page(s) 185

    Language English
    Document type Article
    ZDB-ID 2827037-X
    ISSN 2287-9358
    Database Current Contents Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Article ; Online: Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh.

    Kamrul-Hasan, A B M / Hannan, Mohammad Abdul / Alam, Muhammad Shah / Rahman, Mohammad Motiur / Asaduzzaman, Md / Mustari, Marufa / Paul, Ajit Kumar / Kabir, Md Lutful / Chowdhury, Sumon Rahman / Talukder, Samir Kumar / Sarkar, Sourav / Hannan, Muhammad Abdul / Islam, Md Rashedul / Iftekhar, Mohammad Hasan / Robel, Md Abdul Bari / Selim, Shahjada

    BMC endocrine disorders

    2023  Volume 23, Issue 1, Page(s) 37

    Abstract: Introduction: Insulin pen devices and disposable plastic insulin syringes are two common tools for insulin administration. This study aims to compare the simplicity, convenience, safety, and cost-effectiveness of insulin pens versus syringe devices in ... ...

    Abstract Introduction: Insulin pen devices and disposable plastic insulin syringes are two common tools for insulin administration. This study aims to compare the simplicity, convenience, safety, and cost-effectiveness of insulin pens versus syringe devices in patients with type 2 diabetes mellitus (T2DM).
    Methods: A cross-sectional study was conducted at 14 diabetes clinics throughout Bangladesh from November 2021 to April 2022 among adults with T2DM injecting insulin by pen devices or disposable insulin syringes at least once a day for at least one year by purposive sampling. The simplicity, convenience, and safety of insulin devices were assessed using a structured questionnaire, and the study subjects were scored based on their answers; higher scores indicated a poorer response. Total scores for simplicity, convenience, and safety were obtained by adding the scores for relevant components. Their average monthly medical expense and cost of insulin therapy were recorded. The median values of the total scores and monthly expenses were compared between pen devices and disposable syringe users.
    Results: 737 subjects were evaluated; 406 were pen users, and 331 were vial syringe users. The pen users had lower median scores for simplicity [6.0 (5.0-8.0) vs. 7.0 (5.0-9.0), p = 0.002], convenience [4.0 (3.0-6.0) vs. 5.0 (4.0-6.0), p < 0.001], and safety [7.0 (6.0-8.0) vs. 7.0 (6.0-9.0), p = 0.008] than vial syringe users. Pen devices were more expensive than vial syringes in terms of average medical expense per month [BDT 5000 (3500-7000) vs. 3000 (2000-5000), p < 0.001], the total cost of insulin therapy per month [BDT 2000 (1500-3000) vs. 1200 (800-1700), p < 0.001] and cost per unit of insulin used [BDT 2.08 (1.39-2.78) vs. 0.96 (0.64-1.39), p < 0.001]. Non-significant differences in favor of pens were observed in HbA1c levels [8.7 (7.8-10) vs. 8.9 (7.9-10)%, p = 0.607] and proportions of subjects having HbA1c < 7% (6.9 vs. 6.3%, p = 0.991).
    Conclusion: Insulin pens are simpler, more convenient, and safe but more expensive than vial syringes. Glycemic control is comparable between pen and syringe users. Long-term follow-up studies are needed to determine the clinical and economic impacts of such benefits of insulin pens.
    MeSH term(s) Adult ; Humans ; Bangladesh/epidemiology ; Cost-Benefit Analysis ; Cross-Sectional Studies ; Diabetes Mellitus, Type 2/drug therapy ; Disposable Equipment ; Glycated Hemoglobin ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/therapeutic use ; Insulin/administration & dosage ; Insulin/therapeutic use ; Retrospective Studies ; Syringes ; Drug Delivery Systems
    Chemical Substances Glycated Hemoglobin ; Hypoglycemic Agents ; Insulin
    Language English
    Publishing date 2023-02-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2091323-0
    ISSN 1472-6823 ; 1472-6823
    ISSN (online) 1472-6823
    ISSN 1472-6823
    DOI 10.1186/s12902-023-01292-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top